Paraclostridium tenue Exhibits Antitumor Activity Through Generating Antitumor Metabolites and Modulating Gut Microbiota
Open Access
Abstract
Colorectal cancer (CRC) is a digestive tract malignant tumor with a relatively high incidence and mortality rate worldwide. The occurrence and development of CRC are closely associated with disturbances in the gut microbiota. Paraclostridium tenue (synonym Eubacterium tenue) is generally considered a harmless commensal and can be isolated from fecal samples of healthy adults. However, whether this bacterium is a beneficial organism with an antitumor effect is unknown. This study systematically evaluated the anti-CRC effects of P. tenue strain Pt517 on CRC cells in vitro and in the CT26 syngeneic mouse model. Pt517 culture supernatant (Pt517CS) inhibited the proliferation, colony formation, and migration ability of CRC cells; induced cell apoptosis; and altered cell cycle distribution. Daily intragastric administration of Pt517 significantly inhibited tumor growth in mice; increased the expression levels of TNF-α, INF-γ, and CD8 in tumor tissues; and decreased the levels of IL-6, IL-10, and TGF-β. Pt517 intervention significantly modulated the gut microbiota composition with increased relative abundance of Parabacteroides goldsteinii, Lachnospiraceae, and Enterorhabdus caecimuris B7. The long-chain fatty acids (LCFAs), stearic acid and palmitic acid, were increased in the serum of treatment group mice and detected in Pt517CS. Functional verification indicated that stearic acid and palmitic acid directly inhibited the proliferation of CT26 cells in a dose-dependent manner, suggesting that Pt517 might exert its anti-CRC effect by secreting LCFAs. These findings indicate that P. tenue Pt517 is a potential new candidate for the microbial treatment of CRC, which warrants further validation for its safety and efficacy before clinical translation.Keywords
Funding Information
- Comprehensive Innovation Capability Support of Intelligent Tracking and Forecasting for Infectious Diseases (102393240020020000004)
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (2025NITFID502)
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (2025NITFID513)
This publication has 74 references indexed in Scilit:
- Male‐Biased Gut Microbiome and Metabolites Aggravate Colorectal Cancer DevelopmentAdvanced Science, 2023
- Probiotics Influence Gut Microbiota and Tumor Immune Microenvironment to Enhance Anti-Tumor Efficacy of DoxorubicinProbiotics and Antimicrobial Proteins, 2023
- Spent culture supernatant of Streptococcus gordonii mitigates inflammation of human periodontal cells and inhibits proliferation of pathogenic oral microbesJournal of Periodontology, 2023
- Exploring the Role of Gut Microbiome in Colon CancerApplied Biochemistry and Biotechnology, 2021
- Correction to: Ceramide and palmitic acid inhibit macrophage-mediated epithelial–mesenchymal transition in colorectal cancerMolecular and Cellular Biochemistry, 2020
- The effect of palmitic acid on inflammatory response in macrophages: an overview of molecular mechanismsInflammation Research, 2019
- Tribbles 2 (Trib2) is a novel regulator of toll-like receptor 5 signalingInflammatory Bowel Diseases, 2012
- The Production of Conjugated α‐Linolenic, γ‐Linolenic and Stearidonic Acids by Strains of Bifidobacteria and PropionibacteriaLipids, 2011
- The dimensions of the CRC problemBest Practice & Research Clinical Gastroenterology, 2010
- Escherichia coli as a model for the regulation of dissociable (type II) fatty acid biosynthesisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996